Home Stocks Neuland Laboratories Ltd

Neuland Laboratories Ltd

The live share price of Neuland Laboratories Ltd (NEULANDLAB) as on 27 May 10:21am is ₹6,327.6 from NSE/BSE.

NEULANDLAB NSE

₹6,327.6 ▼-0.09% (-5.95)

As on May 27, 2024 03:51 PM IST

How do you feel today about Neuland Laboratories Ltd?

Key Metrics

PE Ratio

27.08

PB Ratio

8.17

Dividend Yield

0.22%

Sector PB

5.98

Sector PE

42.12

Sector Div Yld

0.63%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Smallcap, ₹8,125 Cr

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredients and intermediates.

The following charts display the financial performance of the Neuland Laboratories Ltd (NEULANDLAB) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Neuland Laboratories Ltd (NEULANDLAB), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

sec-img

Sector

Health Care

sec-img

Industry

Pharmaceuticals

sec-img

Market Cap

Smallcap, ₹8,125 Cr

Financials

Income Statement

(INR) Y/Y Change
Revenue 1,571 Cr +30.82%
Operating Expense 1,095 Cr +1039.76%
Net Income 300 Cr +83.51%
Net Profit Margin 19.1% +40.23%
Earning Per Share 233 +83.51%
EBITDA 475 Cr +68.73%

Balance sheet

(INR) Y/Y Change
Cash & short-term Inv 59 Cr +148.95%
Total Assets 1,579 Cr +14.19%
Total Liabilities 585 Cr +7.85%
Total Equity 994 Cr +18.27%
Shares Outstanding 1.28 Cr -0.23%
Price to Book 2.33 +40.65%
Return on Assets 11.04% +134.39%
Return on Capital 23.02 Cr +102.28%

Cash Flows

(INR) Y/Y Change
Net Income 300 Cr +83.51%
Cash from Operations 237 Cr +292.8%
Cash from Investing -61 Cr -36%
Cash from Financing -135 Cr -460.02%
Net Change in Cash 40 Cr +1415.79%
Free Cash Flow 171 Cr -558.66%
Total Promoter Holding
32.74%
Unpledged
Foreign Institutions
24.44%
Foreign Institutions
Retail & Others
36.28%
Retail & Others
Other Parties
Other Domestic Institutions
2.66%
Insurance Firms
Others
Mutual Funds
3.88%
Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

37.25

1Y Return

▲51.38%

CIPLA

Cipla Ltd

PE Ratio

29.12

1Y Return

▲54.63%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

28.05

1Y Return

▲106.72%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

17.51

1Y Return

▲28.89%

Latest News

latest-news

Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms - News18

1 month ago on News18

Change since news 0%

It has revised its target prices for Syngene International Limited and Neuland Laboratories Ltd.


FAQs on Neuland Laboratories Ltd

How to buy Neuland Laboratories Ltd stocks?

You can easily buy the stocks/shares of Neuland Laboratories Ltd (NEULANDLAB) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Neuland Laboratories Ltd?

The stock price of Neuland Laboratories Ltd as on 27 May 2024 is ₹6,327.6

What is the 52-week High and Low of Neuland Laboratories Ltd?

The 52-week high and low of Neuland Laboratories Ltd (NEULANDLAB) is ₹7,790 and ₹2,603.6.

What is the PE and PB ratio of Neuland Laboratories Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Neuland Laboratories Ltd are 27.08 and 8.17 respectively.

What are the peers or stocks similar to Neuland Laboratories Ltd?

The peers or stocks similar to Neuland Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Zydus Lifesciences Ltd, Dr Reddy's Laboratories Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Neuland Laboratories Ltd belong to?

Neuland Laboratories Ltd (NEULANDLAB) belongs to the Pharmaceuticals sector.

What is the Market Cap of Neuland Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Neuland Laboratories Ltd (NEULANDLAB) is ₹8,125 Cr as of 27 May 2024

Can't decide whether or not to buy Neuland Laboratories Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.